Skip to main content
Figure 7 | Molecular Pain

Figure 7

From: ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response

Figure 7

Effect of ARA 290 on GFAP immunoreactivity after spared nerve injury. Quantification graphs showing GFAP immunoreactivity (percentage of immunostained area) in sections of different lumbar spinal cord levels (L1-L6) from animals 2 weeks (panel A) or 20 weeks (panel B) after sham-operation (grey), spared nerve injury and vehicle-treated (red), spared nerve injury and treatment with 10 μg/kg ARA 290 (green), or spared nerve injury and treatment with 30 μg/kg ARA 290 (marine). Data are mean ± SEM.

Back to article page

Molecular Pain

ISSN: 1744-8069

Contact us